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Abstract
The treatment of anisometropic or ametropic amblyopia
has traditionally enjoyed a high treatment success rate.
Early initiation and consistent use of spectacle correction
can completely resolve amblyopia in a majority of
patients. For those with anisometropic amblyopia that
fail to improve with glasses wear alone, patching or
atropine penalisation can lead to equalisation of visual
acuity. However, successful treatment requires full-time
compliance with refractive correction and this can be a
challenge for a patient population that often has one
eye with good acuity without correction. Other barriers
for a select population with high anisometropic or
ametropic amblyopia include rejection of glasses for
various reasons including discomfort, behavioural or
sensory problems, postural issues and visually significant
aniseikonia. When consistent wear of optical correction
proves difficult and patching/atropine remains a major
obstacle, surgical correction of refractive error has proven
success in achieving vision improvement. Acting as a
means to achieve spectacle independence or reducing
the overall needed refractive correction, refractive surgery
can offer a unique treatment option for this patient
population. Laser surgery, phakic intraocular lenses and
clear lens exchange are three approaches to altering the
refractive state of the eye. Each has documented success
in improving vision, particularly in populations where
glasses wear has not been possible. Surgical correction
of refractive error has a risk profile greater than that of
more traditional therapies. However, its use in a specific
population offers the opportunity for improving visual
acuity in children who otherwise have poor outcomes
with glasses and patching/atropine alone.

Introduction
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A significant difference in refractive error
(anisometropia) or a large degree of refractive error
in both eyes (isoametropia) predisposes a child to
the development of amblyopia. Anisometropia
may occur in the setting of asymmetric myopia,
hyperopia or astigmatic error. The amount of
anisometropia that may generate amblyopia is not
concrete, but the results of the Multi-Ethnic Pediatric Eye Disease Study established that 59.5% of
subjects with ≥2 dioptre (D) spherical equivalent
(SE) of anisometropia had amblyopia.1 The risk
for amblyopia development is seen with relatively
smaller differences in hyperopia (≥1.50 D SE)
or astigmatism (≥2 D SE). In contrast, <3 D SE
of anisometropia myopia does not usually cause
amblyopia.2 3 Ametropia guidelines are less exact
but concern is that those refractions of ≥4 D of

hyperopia, ≥2.50 D of astigmatism or ≥6 D of
myopia place a child at risk for amblyopia.2 4
Standard of care practice for refractive amblyopia
includes correction of the refractive error using
glasses followed by patching or atropine penalisation of the fellow eye for anisometropic amblyopia.
Studies by the Pediatric Eye Disease Investigator
Group (PEDIG) have carefully defined the amount,
duration and options for the modification of both
patching and atropine therapy.5–8 Further improvement in visual acuity occurs with addition of a plano
lens in the fellow, non-amblyopic eye.9 10
Successful treatment, however, is predicated
on full-time compliance with refractive correction. Anisometropic children often have one eye
with good acuity without correction; therefore,
they perceive little benefit from glasses and may
reject them. Other barriers to spectacle compliance include intolerance for a myriad of reasons
including discomfort with wear, sensory disorders
and postural issues. Furthermore, higher degrees
of anisometropia may cause visually significant
aniseikonia. Two to three dioptres of anisometropia
induces 5%–6% aniseikonia, a challenging amount
of image disparity for the brain to resolve.11
High isoametropia, especially those cases of
severe bilateral myopia, can cause bilateral amblyopia or reduced best-corrected visual acuity (BCVA).
Amblyopia can occur whenever high refractive
error exists, even in the context of compliance with
spectacle correction. Object minification due to
high myopic lenses limits acuity and contributes to
limited BCVA.12
Contact lens correction (CTL) for the amblyopic
eye in children with significant anisometropia is an
acceptable alternative to spectacle correction. CTL
do not induce aniseikonia for the same degree of
correction and have the benefit of only nominal
image minimisation for children with high myopic
refractive errors. However, the barriers to CTL
correction are similar to those for spectacle wear
(no perceived benefit, discomfort, intolerance).
Additional limitations include parents discomfort
with CTL handling and placement and the lack of
coverage on most insurance plans, which further
dampens parent’s enthusiasm for this approach.
When optical correction cannot be consistently
worn, patching/atropine remains a major obstacle,
or for the small subset of patients who have excellent compliance with glasses and amblyopia treatments, yet continue to stall in visual improvement,
evidence suggests surgical refractive correction is a
reasonable option to combat amblyopia. The benefits of surgical correction of refractive error are
manifold. It eliminates compliance with refractive
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correction for any reason as a barrier to amblyopia treatment and
has the same benefits as CTL without the associated perceived
and real drawbacks of CTL use in the paediatric population.
Furthermore, the ability to reduce anisometropia and resulting
aniseikonia, even with residual spectacle dependence, is a positive—and unique—benefit to surgical correction in the treatment of amblyopia.

Laser surgery

Photorefractive keratectomy (PRK), laser in situ keratomileusis
(LASIK) and laser-assisted subepithelial keratectomy (LASEK)
have been used to effectively treat refractive errors in the children. The first reported use of laser-assisted refractive surgery
in children was published by Singh in 1995.13 Since that time,
numerous case reports and series have documented both the
safety and efficacy of the operation in these patient cohorts.
The utility of the procedures has been documented to treat high
hyperopia, high myopia and large amounts of astigmatism. To
date, no randomised controlled trial has documented the effectiveness of laser-assisted refractive surgery in the treatment of
amblyopia.
Use of laser-assisted refractive surgery for the treatment of
myopic anisometropia has been reported in over 17 case series.
Yin et al described successful use of LASEK in myopic astigmatism (SE ranged from −15.8 D to −5.4 D) in 32 children.
BCVA improved from 20/50 to 20/33 and the rates of stereopsis
improved from 19% to 73%. Incidence of corneal haze was
low (6/32) and mild.14 In a similarly sized study of 35 patients,
Tychsen et al treated an even greater range of anisomyopia (SE
−3.3 D to −24.3 D) using PRK and LASIK.15 Mean BCVA
improved from 20/87 to 20/47. Low rates of haze were reported.
Paysse et al reported a similar patient cohort with over 3 years of
follow-up. This population also included myopes ranging from
−21.0 D to −9.75 D. In this report, the maximum treatment
dose was −11.5, which allowed for successful treatment of high
myopes taking into consideration the need to leave a sufficient
residual stromal bed.16 Overall, the published studies document
a trend towards improvement in BCVA. Low rates of complications were reported in all studies and included minimal haze and
two incidents of flap dislocation in LASIK patients.
Treatment of anisohyperopia with corneal refractive surgery
is less extensively reported. It differs from myopic treatments
in the size and shape of the ablation zone, rendering it slightly
more challenging and prone to regression.17 18 PRK, LASEK
and LASIK have shown promise in improving BCVA, binocular
vision and density of amblyopia. Dvali et al studied an older
population, mean age of 12.7 years, and had encouraging results.
Twenty-four patients had improvement in amblyopia and twenty
had it completely resolve.19 Reassuringly, even treatment of high
hyperopes did not lead to high rates of corneal haze. Astle and
colleagues reported on the results of 47 patients undergoing
LASEK in 72 eyes for the treatment of bilateral hyperopia and
hyperopic anisometropic amblyopia.18 In this cohort, the upper
limit of hyperopia treated was +12.5. Among the children able
to complete acuity testing, a 41.7% improvement in distance
acuity was seen. There was also improvement in gross and fine
stereopsis.
High isoametropia, especially severe bilateral myopia, can
cause bilateral amblyopia or reduced BCVA. Poor spectacle
compliance is a primary contributing factor to the development
of bilateral amblyopia. While this is often seen in the setting
of developmental delay and/or neurobehaviourally impaired
children who struggle with glasses wear, amblyopia can occur
1612

whenever high refractive error exists. Minification due to
high myopic lenses also limits acuity.17 Astle also included an
example of high bilateral hyperopia in an 11-year old who,
despite excellent glasses compliance, could not achieve BCVA
better than 20/80. With LASEK, he improved to 20/40, although
the postoperative course was complicated by 2+corneal haze.18
The combined effect of additional magnification and improved
uncorrected visual acuity can have impressive effects on overall
function.16 20
Laser refractive surgery for children is not yet a perfect solution for the treatment of amblyopia. Despite being well tolerated, having low rates of visually significant complications and
repeatedly documented BCVA gains, there remains room for
improvement. Regression occurs across all groups of preoperative refractive errors.16 Some surgeons advocate the application of the antimetabolite mitomycin C during treatment to
reduce regression in both myopic and hyperopic treatments, but
controlled studies are lacking.21 Most regression occurs over the
first year following surgery, with smaller shifts over the following
2–3 years. Treatment for high myopia generally shows even
faster rates of regression. Authors suggest anticipating this shift
and overcorrecting by 1–2 D. Therefore, laser-assisted refractive
surgery may not free a child from spectacle dependence. Moreover, while the assumption was that with reduced anisometropia
glasses and patching compliance should improve, but this was
not reported to be the case.16
Studies have suggested that amblyopia treatment of large
refractive errors with refractive surgery should take place
while younger to maximise visual rehabilitation. Astle reported
successfully treated dense amblyopia from anisomyopia and
anisoastigmatism in children less than 1 year of age.22 Refractive
errors were quite large in these cases and amblyopia was felt
to be unresponsive to all prior forms of treatment. It follows
that treatment in this age range will require general anaesthesia.
The logistics of arranging for anaesthesia staff and supplies in
facilities already containing excimer laser can be complicated.
However, a practical framework for PRK with general anaesthesia has been outlined by Paysse and colleagues.23
Drawbacks linked to treatment-specific complications are as a
whole quite low. Severe vision compromising complications are
exceptionally rare. Instances of flap dislocations among LASIK
patients are reported in the literature, but remain reassuringly
infrequent.24 Reports of corneal haze are low and generally did
not become visually significant.16 Most resolved with the use of
topical steroids. Surgeons continue to look for ways to improve
their techniques and outcomes, especially in regards to corneal
clarity and refractive targets. The use of femtosecond technology, mitomycin C and more precisely selecting good refractive candidates are all the ways future refractive outcomes may
continue to improve.

Phakic intraocular lenses (pIOLs)

pIOLs are available in three models: iris-fixated anterior chamber,
ciliary sulcus-supported posterior chamber and angle-supported
anterior chamber. The preference currently appears to be for
iris-claw anterior chamber IOLs. As noted by Cleary et al, the
creation of iris-claw lenses took place in the 1970s with the
original models of what currently are the Artisan and Verysise
lenses.25 They have undergone modification in the decades since
and now feature a biconvex design. Hyperopic correction ranges
from +2 to+30 D and myopic correction ranges from −1.00 to
−23.50 D. Toric configurations of the Artisan lens can correct
up to 7.50 D of astigmatism. Use of the iris-claw lens was first
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reported in children in 1997 in a series of 38 eyes of 27 aphakic
children.26
High anisomyopic amblyopia has been successfully corrected
using Artisan and Verysise lenses.20 27–29 Pirouzian and Ip reported
the successful rehabilitation of seven patients (age 5–11 years)
with greater than 8 D of myopia with the use of Verysise lenses.
Each child was entered into the study with a BCVA <20/100. At
follow-up 3 years later, mean BCVA was 20/40 (range 20/30–
20/60). The mean SE refraction was −14.28 D preoperatively
and −1.10 D 3 years postoperatively.30 In this group of neurodevelopmentally normal but non-compliant patients, all improved
with spectacle wear and occlusion therapy postoperatively.
Tychsen et al reported the successful implantation of Artisan/
Verysise lenses in high myopia and hyperopia in a group of 12 children with neurobehavioural disorders.20 This group of patients
with long-term, severe refractive error has been diagnosed with
‘visual autism’ (a constellation of symptoms including decreased
interest in the outside world, fearfulness and markedly withdrawn social interaction) by the authors.30–33 This report also
referenced the successful treatment of a high hyperope (mean SE
+10.3) and outlined the utility of pIOLs in the visual rehabilitation of this group of neurodevelopmentally delayed children.
While not all patients were able to complete comprehensive eye
examinations, documented improvement by caregivers in visual
awareness, attentiveness or social interactions was reported.
Using validated visual function questionnaires, scores improved
after surgery by 73% in bilateral ametropes and by an average
58% in anisometropes.20
The Visian implantable collamer lens pIOL is a foldable
posterior chamber pIOL designed to be placed in the posterior
chamber behind the iris with the haptic zone resting on the
ciliary sulcus. This has been approved for use in the correction
of myopia in adults.34 Correction of anisometropic amblyopia
in both myopes and hyperopes has been reported with its use. A
toric form of this lens allowed for successful targeting of astigmatic anisometropia in children.35
Foremost among concerns about enclavation of pIOLs was
potential damage to endothelial cells. Improvements in lens
design have dramatically increased the safety profile. In adults,
endothelial cell loss has been strictly monitored and remains
a concern, but has not proved significant enough to deter use
of the lens. Long-term follow-up of endothelial cell densities
includes reports with up to 12 years of follow-up data.36 Guidelines also specify the use of pIOLs only in situations where anterior chamber depth >3.2 mm.17 Alio et al provided 5 years of
follow-up on nine children implanted with iris-fixated pIOL for
anisometropic amblyopia, and endothelial cell count was >2000
cells/mm2 in 80% of patients. For the remaining patients, eye
rubbing and ocular trauma was implicated in endothelial cell
loss.37 Dislocation, pigment dispersion or iris trauma, cataract
formation and shallowing of the anterior chamber are reported
rare events in adults.38

Clear lens exchange (CLE)

For extreme refractive errors (>−15.0 D) or instances of shallow
anterior chambers (<3.2 mm), CLE or refractive lens exchange
is a suitable solution. With increasing evidence supporting the
use of IOLs in paediatric cataract surgery, many paediatric
ophthalmologists feel comfortable with the skills required for
CLE.39 40 Turning to CLE for ametropia or lensectomy alone
for high myopes is an effective means to improve in refractive
error.41 42 Tychsen and coauthors were able to improve visual
acuity (VA) and correct ametropia within range of the target

refraction. Average gains in VA are less than that seen in other
forms of refractive surgery. The authors suggest that their cohort
had poorer initial acuity and ocular comorbidities than other
studies of refractive surgery, limiting potential gains.
In contrast to the regression seen after laser correction, which
may average ∼1 D/year, myopic regression after lens extraction
appears to be less, on the order of ∼0.5 D/year.37 Regression
tends to be more pronounced in younger groups of patients
who undergo CLE.
Highly myopic eyes make up the largest cohort of patients
receiving CLE or lensectomy and are inherently at greater risk
for retinal detachments. It has been established in adults that
risk increases threefold following lens extraction.43 Prophylactic
barrier laser remains controversial.44 In one study in children,
one patient sustained a detachment following trauma months
after CLE.37 Other reports include a higher than expected rate of
posterior capsule opacification. Most include primary posterior
capsulotomy as a routine part of their procedure, but still warn
it may need to be repeated.

Summary/conclusions

Refractive surgery has demonstrated benefits for the population
of children with refractive amblyopia who are non-compliant
with spectacle wear or non-responsive to standard treatment
in multiple case series. Evidence also suggests that correction
of ametropia in children with neurobehavioural disorders that
preclude spectacle correction improves not only vision but
also global functioning. Clear lens extraction has shown some
benefit, but not the robust gains that PRK and pIOL treatments
have demonstrated. While there are no randomised controlled
trials to support widespread adoption of these techniques,
PEDIG is currently planning Amblyopia Treatment Study 19,
which is a controlled randomised clinical trial that will compare
PRK versus non-surgical treatment of anisometropic amblyopia
in children who have failed conventional treatment. The results
from this trial may provide yet more evidence for the use of
refractive surgery in the management of amblyopia.
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